Alcidion Group Limited (ASX:ALC) has released Chair Rebecca Wilson's address and presentation slides from the company's 2026 Annual General Meeting, held on 12 November 2026, disclosing details on financial performance, capital allocation priorities, a share buyback, a proposed share consolidation, and guidance for FY27.

Key Points

  • Chair Rebecca Wilson described FY26 as Alcidion's strongest financial performance to date, with growth across every key measure and a debt-free balance sheet at year end.
  • The company reconfirmed guidance that FY27 revenue and underlying EBITDA will exceed FY26 levels.
  • Alcidion won its third Electronic Patient Record contract and acquired Kyra Health during the year.
  • An on-market share buyback and a proposed share consolidation were both referenced at the meeting.
  • The Board has commissioned an independent remuneration review, with further disclosure to be provided in the next Remuneration Report.

FY26 Financial Performance and Profitability

According to the Chair's address, Alcidion delivered what was described as its strongest financial performance to date in FY26, building on the profitability first achieved in FY25. The company converted earnings into cash and finished the year with a strong balance sheet and no debt. The address stated that more of the company's revenue now comes from recurring, multi-year partnerships with health systems across Australia, New Zealand and the United Kingdom. The company also disclosed it enters FY27 with record contracted revenue and a growing base of recurring income.

Third EPR Contract Win and Kyra Health Acquisition

The filing disclosed that during FY26, Alcidion secured its third Electronic Patient Record contract and completed the acquisition of Kyra Health. The Chair's address stated the Kyra Health acquisition was intended to strengthen Alcidion's leadership in patient flow in Australia and substantially increase its customer footprint. The filing also noted that flagship customers continued to expand their use of Alcidion's platform by adding new modules and deepening their partnerships. According to the company's about section, Alcidion currently services over 400 hospitals and 87 healthcare organisations.

Capital Allocation Framework and Governance Initiatives

The Chair's address outlined a capital allocation framework covering continued investment in the Miya platform, including AI-enabled capability, pursuit of growth in existing and new markets, consideration of earnings-accretive acquisitions, and return of capital to shareholders where appropriate. The on-market share buyback was described as one example of this framework in action. A proposed share consolidation was put to shareholders at the meeting. The filing also stated that the Board has formalised a policy requiring directors to hold shares equal to at least one year's fees within three years of appointment, and that an independent remuneration review has been commissioned.